Creo Medical (GB:CREO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Creo Medical Group PLC has announced the successful completion of its Retail Offer, resulting in the issuance of 369,109 shares at 24 pence each. These new shares, along with an additional 50 million Placing Shares, will be traded on the AIM market of the London Stock Exchange starting October 21, 2024, pending shareholder approval. This move highlights Creo’s commitment to expanding its innovative electrosurgical medical device portfolio.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.